Compare PCRX & AVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PCRX | AVO |
|---|---|---|
| Founded | 2006 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Farming/Seeds/Milling |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.0B |
| IPO Year | 2010 | 2020 |
| Metric | PCRX | AVO |
|---|---|---|
| Price | $23.36 | $11.13 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | ★ $30.25 | $17.00 |
| AVG Volume (30 Days) | 517.6K | ★ 864.8K |
| Earning Date | 04-30-2026 | 06-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 107.44 | 1.92 |
| EPS | ★ 0.07 | N/A |
| Revenue | $541,533,000.00 | ★ $1,391,200,000.00 |
| Revenue This Year | $6.78 | N/A |
| Revenue Next Year | $8.54 | $3.06 |
| P/E Ratio | $338.29 | ★ N/A |
| Revenue Growth | ★ 26.04 | 12.68 |
| 52 Week Low | $18.80 | $10.37 |
| 52 Week High | $27.64 | $15.53 |
| Indicator | PCRX | AVO |
|---|---|---|
| Relative Strength Index (RSI) | 48.10 | 25.15 |
| Support Level | $22.06 | $10.37 |
| Resistance Level | $24.20 | $12.21 |
| Average True Range (ATR) | 1.04 | 0.45 |
| MACD | 0.05 | -0.12 |
| Stochastic Oscillator | 44.31 | 0.78 |
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
Mission Produce Inc produces, packs, and distributes mainly Hass avocados to retail, wholesale, and food service customers, offering pre-ripe and ripened fruit tailored to customer specifications through its network of ripening facilities. The Company operates through three segments: Marketing & Distribution, which sources and distributes fruit globally and generates the majority of revenue; International Farming, which owns and operates avocado orchards and supplies fruit mainly to Marketing & Distribution, with operations principally in Peru and Guatemala; and Blueberries, which farms blueberries sold under an exclusive marketing agreement. The Company's operations span Peru, the United States, Guatemala, Mexico, Europe, and Canada.